JPRN-UMIN000010733已完成2 期
Phase II study of Bevacizumab + Pemetrexed in elderly patients with advanced non-squamous non-small-cell lung cancer - Phase II study of BEV + PEM in elderly patients with advanced non-squamous non-small-cell lung cancer
Central Japan Lung Study Group0 个研究点目标入组 37 人开始时间: 2013年5月16日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 37
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 75years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) symptomatic brain metastasis 2) History of hemoptysis with 2.5mL or more 3) severe comorbidity (cardiovascular disease, pulmonary fibrosis/interstitial pneumonia, tendency to hemorrhages, uncontrolled hypertension or diabetes) 4) History of active double cancer within 5 years. 5) uncontrolled retention of fluid 6)receiving more than two anticoagulant drugs 7) active gastrointestinal bleeding or intraperitoneal inflammation 8) other inadequacy cases judged by attending physician
研究者
相似试验
招募中
2 期
A phase II study of Bevacizumab plus Pemetrexed for previously treated Non Small Cell Lung Cancer with T790M mutatioon-small cell lung cancerJPRN-UMIN000008032Toho University Omori Medical Center15
招募中
2 期
A Phase II study of Pemetrexed/Bevacizumab in patients ineligible for platinum-based chemotherapy with untreated Advanced Non-squamous non-small-cell lung cancer (ALCT003)on-squamous Non-small cell lung cancerJPRN-UMIN000010805Department of Respiratory Medicine Kyorin Univercity Hospital25
招募中
2 期
Phase II study of Pemetrexed and Bevacizumab in Performance status 2 patients with advanced non-squamous non-small cell lung cancer.JPRN-UMIN000008124iigata Lung Cancer Treatment Group25
已完成
2 期
Phase II study of Pemetrexed and Bevacizumab in Plutinum Unfit patients with untreated advanced non-squamous non-small cell lung cancer(OSAKA-LCSG1201)non-small cell lung cancerJPRN-UMIN000009539OSAKA-LCSG45
尚未招募
2 期
A phase II trial of pemetrexed/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer.elderly patients with stage IIIB/IV non-small cell lung cancer except for squamous cell carcinomaJPRN-UMIN000008764Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, The University of Tokushima Graduate School36